Novo Nordisk is the largest insulin maker in the world and with [type 2] diabetes on the rise you would think that business is good for them. Well, if things are swimming along nicely for Novo Nordisk, then why are they cutting approximately 1,000 jobs as part of a plan to lower costs? It might […]
